Mirae Asset Global Investments Co., Ltd. Taysha Gene Therapies, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 7,412 shares of TSHA stock, worth $10,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,412
Previous 5,583
32.76%
Holding current value
$10,525
Previous $12,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TSHA
# of Institutions
116Shares Held
137MCall Options Held
65.4KPut Options Held
41.7K-
Rtw Investments, LP New York, NY18.8MShares$26.7 Million0.7% of portfolio
-
Avoro Capital Advisors LLC New York, NY18.7MShares$26.5 Million0.57% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$16.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$15.4 Million0.37% of portfolio
-
Vr Adviser, LLC New York, NY9MShares$12.8 Million2.21% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $68.7M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...